Introduction
Clinical heterogeneity and phenotypic complexity within a group of disorders collectively known as inherited cholesterol (HDL-C) in plasma. Here we describe a clinical variant of TD in a Japanese patient with HDL deficiency and corneal lipidosis, who carries mutations of ABCA1 in both alleles.
Subjects and methods
The proband was a 48-year-old Japanese male (159 cm, 61 kg) who was being followed clinically by one of us (M.T.) at the outpatient clinic of Hokkaido Hospital for Social Health Insurance. He exhibited severe HDL deficiency, i.e., an almost complete absence of HDL-c and apoAI in plasma, in addition to other findings described in the following paragraphs. Consanguinity was noted, because his parents were first cousins.
Although he had no pathognomonic lesions of TD such as hepato-splenomegaly or peripheral neuropathy, we extended our clinical examination to the patient's whole body and tested him for mutation of the ABCA1 gene, in view of proposals by Assmann (Rust et al. 1999) and Schmitz (Bodzioch et al. 1999 ) that an ABCA1 mutation can be a useful diagnostic marker for incompletely expressed TD. After obtaining informed consent, we examined genomic DNA from the patient and members of his family by direct sequencing of the entire coding region and exon-intron boundaries of ABCA1, according to procedures described previously (Rust et al. 1999) . Briefly, genomic DNA was extracted from peripheral leukocytes, and all 50 exons, including exon-intron junctions, were individually amplified by polymerase chain reaction (PCR) with primers designed according to archived sequences (Accession numbers AF165281 and AF275948; Santamarina-Fojo et al. 2000) . Each PCR product was sequenced directly on both strands, as described by Wu et al. (2000) . We tested for the observed R1680W mutation in the proband and relatives using the PCR-restriction fragment length polymorphism (RFLP) method, by amplifying a 351-bp fragment of exon 37 with primers 5Ј-TTGACTGTTGCCCCTTATCTA-3Ј and 5Ј-ATGCCCCTGCCAACTTTACC-3Ј and digesting the product with BsrBI. Samples were electrophoresed in a 3% agarose gel and the bands were visualized with ethidium bromide.
Results
The patient (P) was found to be homozygous for a C-to-T transition at nucleotide 5038 (codon 1680, exon 37) of ABCA1, which would result in substitution of Trp for Arg (1680W). The patient's three sons (S1, S2, S3) were all heterozygous for this substitution. Figure 1 shows PCR-RFLP diagnosis of these four family members. We did not detect the substitution in any of 192 control chromosomes from unrelated Japanese individuals. However, we did note in our patient a frequent polymorphism, GAEA at 4760, that had been described previously in the Japanese population (Iida et al. 2001) ; the proband was homozygous for the minor allele. He carried no mutations in his apoAI or LCAT genes. The proband, but none of his children with heterozygosity for the ABCA1 mutation, displayed marked reduction in plasma levels of HDL-c, apoAI, and apoAII (Table 1) .
On closer examination of the proband using coronary angiography and computerized tomography (Fig. 2) , we observed bilateral corneal lipidosis and progressive occlusion of the anterior descending (#7) and circumflex (#11) regions of the left coronary artery (Fig. 2B) . Hepatosplenomegaly and peripheral neuropathy were absent (Fig. 2) . He had undergone tonsillectomy in childhood. Thus, molecular testing of the ABCA1 gene led us to a diagnosis of TD in a patient who manifested atypical symptoms of that disease and might otherwise have been diagnosed merely with isolated HDL deficiency. 
Discussion
Germline mutation in our proband had occurred in the intracellular loop of the second half of six membranespanning domains, where amino-acid sequence is highly conserved among species. Most of the germline missense mutations of ABCA1 reported in patients with typical TD have occurred within the first extracellular loop of the first half of the membrane-spanning domain and the nucleotidebinding fold (Bodzioch et al. 1999; Brooks-Wilson et al. 1999) . Functional consequences of mutations occurring in different regions of the predicted protein might well relate to the phenotypic differences between our patient and carriers of typical TD. An autosomal recessive mode of inheritance, a severe deficiency or absence of HDL in plasma, and an accumulation of cholesterol in many tissues characterize the clinical syndrome in TD patients who are homozygous for mutation of the ABCA1 gene. Defects in this gene lead to the accumulation of cholesteryl ester in cells as a result of abnormal cholesterol efflux, normally the first step in reverse cholesterol transport (Orso et al. 2000) . We suspect that apparent HDL deficiency patients in Japan who carry ABCA1 germline mutations (Huang et al. 2001; Nishida et al. 2002) may in fact belong to a category of TD patients whose phenotypic features are only partially expressed.
We have demonstrated that the presence of a germline ABCA1 mutation can be a reliable diagnostic sign for TD. The results described here signal the possibility that many hidden clinical variants of TD may exist among HDLdeficient patients who might have escaped correct clinical diagnosis. Our work underscores the usefulness and importance of molecular methods for achieving accurate diagnoses of patients with HDL deficiency, because these inherited syndromes may predispose carriers to lifethreatening, premature CAD. 
